Psychiatric disorder
Rare disease
No
- Definition
- A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Psychiatric disorder
- psychiatric disorder
- Illness, Mental
- Mental Illness
- Psychiatric disease
- Psychiatric Diseases
- Psychiatric Disorders
- disease of mental health
- mental disorder
- mental dysfunction
- Severity
- Severe
- MONDO ID
- MONDO:0002025
- Parent condition
- MONDO:7770007
Related records
Broader conditions (3)
- Disease
- Disease by developmental or physiological process
- Human disease
Narrower conditions (427)
- Aceruloplasminemia
- Acute stress disorder
- Adjustment disorder
- Adrenoleukodystrophy
- Adrenomyeloneuropathy
- Agoraphobia
- Agraphia
- AIDS dementia complex
- AIDS phobia
- Alcohol abuse
- Alcohol amnestic disorder
- Alcohol and nicotine codependence
- Alcohol dependence
- Alcohol sensitivity, acute
- Alcohol withdrawal
- Alcohol withdrawal delirium
- Alcohol-induced disorders
- Alcohol-induced mental disorder
- Alcohol-induced Wernicke-Korsakoff's syndrome
- Alcohol-related birth defect
Trials (1,091)
- "Breathlessness Diagnostics in a Box" (BiaB) for Primary Care. A Multi-country Quality Improvement Project Using a Randomized Stepped-wedge Design
- "CoMBI-SMI Multicenter Study: A Person-Centered Cognitive-Behavioral Intervention for Severe Mental Illness"
- "Pilot Study of Music Intervention for Recovery of People With Severe Mental Disorder in the Community"
- "Recovery 4 US" - A Photovoice-based Social Media Program
- 10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
- 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
- 3-year Follow-up of the Mind My Mind RCT
- 3D Ultrasound in Women With Vacuum or Forceps Deliveries
- A Brief Case Management Intervention for People Involuntarily Admitted to a Psychiatric Hospital
- A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions.
- A Brief Mindfulness-Based Intervention for Suicidal Ideation
- A Clinical Study to Map the HLA Genomic Region in the Greek Population
- A Clinical Trial on the Antipsychotic Properties of Cannabidiol
- A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
- A Digital Intervention to Improve Physical Activity and Sleep Behaviors in Youth With Psychiatric Diagnoses
- A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide
- A Dimensional Model for Personality Disorders in Later Life
- A Feasibility Study of a Suicide Prevention Video
- A Feasibility Study to Determine Whether the Botanical Garden Become a Region of Forest Therapy for Cancer Survivors
- A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
Approved drugs (7)
- Beclamide
- Diazepam
- Loxapine
- Olanzapine
- Oxazepam
- Periciazine
- Ziprasidone hydrochloride
Drugs in development (19)
- Aripiprazole Phase 1
- Bifidobacterium SPP. Phase 1
- Buprenorphine Phase 3
- Iloperidone Phase 1
- JNJ-40411813 Phase 2
- Ketamine hydrochloride Phase 1
- Meropenem Phase 3
- Osoresnontrine Phase 2
- Oxytocin Phase 2
- Paliperidone Phase 1
- Psilocybin Phase 2
- Psilocybin trihydrate Phase 2
- Quetiapine Phase 1
- Ralmitaront Phase 2
- Risperidone Phase 1
- TAK-137 Phase 1
- Theanine Early phase 1
- Trospium chloride Phase 1
- Xanomeline Phase 1
Other linked drugs (9)
- Clozapine
- Etomidate
- Ketamine
- Omaveloxolone
- Propofol
- Rocuronium
- Succinylcholine chloride
- Suxamethonium
- Suxamethonium bromide